HappeningToo topic
Vedolizumab reports
Browse community reports connected to Vedolizumab. These reports can show that other people are describing similar experiences, but they do not prove that Vedolizumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
34 problems
Abdominal Discomfort while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and abdominal discomfort appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and abdominal distension appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and abdominal pain upper appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and abdominal pain appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and alopecia appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and anxiety appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and back pain appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and constipation appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and cough appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and decreased appetite appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and dehydration appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and diarrhea appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and dizziness appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and dyspepsia appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and fatigue appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and flatulence appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and headache appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and heart rate increased appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and hives appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and insomnia appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and itching appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and malaise appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and migraine appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and muscle spasms appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and myalgia appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and nausea appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and oropharyngeal pain appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and pain appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and rash appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and shortness of breath appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and vomiting appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and weakness appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and weight decreased appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Vedolizumab
FDA FAERS contains adverse-event reports in which Vedolizumab and weight increased appear together. This does not establish that Vedolizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →